...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What’s the point - short interest doubled lol

& today , who or why does somebody sell 150 shares for 15 penny's a piece??? Strange ain't the word!

- we need to get on a real market & or get this thing sold & the sooner the better!!

Share
New Message
Please login to post a reply